Analysis of transcription factor abnormality in the progression of preleukemic state.
Analysis of transcription factor abnormality in the progression of preleukemic state.
批准号:
08671215
负责人:
MITANI Kinuko
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
我们已经克隆了由t(11 ; 19)(q23 ; p13.1)产生的MIL/MEN(也称为ELL)嵌合基因,其通常在急性髓性白血病或骨髓增生异常综合征衍生的白血病中发现。MIL/MEN融合蛋白含有MLL的氨基末端一半,包括AT钩基序,其与具有富含赖氨酸序列的MEN蛋白融合(K.Mitani等人,BLOOD 85 ; 2017,1995)。因此,MII/MEN融合蛋白可以是嵌合转录因子。用MLL(645-974 a.a.)和MEN的麦芽糖结合融合物(100-179 a.a.),分别这些抗体在转染相应cDNA的Cos 1细胞中检测到MLL/MEN融合蛋白230 kD,MLL缺失型及其下游序列(tMLL)180 kD,MEN蛋白70 kD。使用免疫染色分析和表达MLL/MEN融合蛋白、tMLL和MEN蛋白的Cos 1细胞的亚细胞分级,我们发现, ...更多信息 Conaway等报道MEN是RNA聚合酶II延伸因子(SCIENCE 271 ; 1873,1996)。另一种延伸因子elongin的功能在体外被VHL肿瘤抑制蛋白抑制,这表明异常转录延伸与肿瘤发生可能存在关系。为了证明MEN蛋白的转化活性,将MEN cDNA逆转录病毒导入Rat 1细胞。过表达Men的细胞获得了非贴壁生长的能力。此外,在这些细胞中生长因子的需求减少。然而,表达缺少富含赖氨酸区域的MEN缺失突变体的细胞没有表现出这样的生物学能力。在MEN表达细胞中,c-Fos蛋白表达和AP-1活性升高,这可能是MEN转化的部分机制。c-fos mRNA的表达,其被称为部分地调节在转录延伸的阶段,出现在MEN表达细胞早于在用表皮生长因子刺激后用空载体或缺乏富含赖氨酸的区域的缺失突变体转染的细胞中。MEN的过表达或异常表达可能在白血病向干细胞疾病转化中起重要作用。少
英文摘要
We have cloned an MIL/MEN(also termed as ELL)chimeric gene generated by the t(11 ; 19) (q23 ; p13.1), which is usually found in acute myeloid leukemia or myelodysplastic syndrome-derived leukemia. The MIL/MEN fusion protein contains the amino-terminal half of MLL including AT hook motifs which is fused to the MEN protein with a lysine-rich sequence(K.Mitani, et al. BLOOD 85 ; 2017,1995). Thus, the Mll/MEN fusion protein could be a chimeric transcription factor. Polyclonal antibodies to MLL and MEN were raised in rabbits against GST fusion of MLL(645-974 a.a.)and maltose-binding fusion of MEN(100-179 a.a.), respectively. These antibodies detected the MLL/MEN fusion protein of 230 kD,truncated form of the MLL Without the zinc finger domain and its downstream sequence(tMLL)of 180kD,and MEN protein of 70kD in Cos1 cells transfected with the corresponding cDNAs. Using immunostaining assay and subcellular fractionation of Cos1 cells expressing the MLL/MEN fusion, tMLL,and MEN proteins, we ha … More ve demonstrated that all these proteins exist in the nucleus of the cells.Conaway et al.have reported that the MEN is an RNA polymerase II elongation factor (SCIENCE 271 ; 1873,1996). The function of another elongation factor, elongin, is known to be inhibited by VHL tumor suppressor protein in vitro, suggesting the possible relationship of aberrant transcriptional elongation to oncogenesis. To demonstrate the transforming activity of the MEN protein, the MEN cDNA was introduced retrovirally into Ratl cells. Men-overexpressing cells acquired capacity of anchorage independent growth. In addition, the growth factor requirement was decreased in these cells. However, cells expressing a deletion mutant of MEN lacking the lysine-rich region did not exhibit such biological abilities. The c-Fos protein expression and AP-1 activity were elevated in the MEN-expressing cells, which might be part of the responsible mechanism for the transformation. The c-fos mRNA,the expression of which is known to be regulated partly at the stage of transcriptional elongation, appeared earlier in the MEN-expressing cells than in cells transfected with an empty vector or the deletion mutant lacking the lysine-rich region after the stimulation with epidermal growth factor. Overexpression or aberrant expression of MEN may play an important role in the leukemic tranfformation of stem cell disease. Less
期刊论文(59)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Sasaki K: "TPO/c-MPL ligand induces tyrosine phosphorylation multiple cellular proteins including proto-oncogene produckts,VAV and c-CBL,and RAS signaling molecules." Biochem.Biophys.Res.Commun.216. 338-347 (1996)
Sasaki K:“TPO/c-MPL 配体诱导多种细胞蛋白酪氨酸磷酸化,包括原癌基因产物、VAV 和 c-CBL 以及 RAS 信号分子。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mitani, K., Hangaishi, A., Imamura, N., Miyagawa, K., Ogawa, S., Kanda, Y., Yazaki, Y., Hirai, H.: "No concomitant occurrence of the N-ras and p53 gene mutations in myelodysplastic syndrome." Leukemia. 11. 863-865 (1997)
Mitani, K.、Hangaishi, A.、Imamura, N.、Miyakawa, K.、Okawa, S.、Kanda, Y.、Yazaki, Y.、Hirai, H.:“N-ras 和
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hirai, H., Ogawa, S., Hangaishi, A., Takahashi, T., Hurokawa, M., Mitani, K., Ueda, R., Yazaki, Y.: "Recent progress in molecular mechanisms of leukemogenesis : The cyclin-dependent kinase 4-inhibitor gene in human leukemias." Leukemia. 11. 358-360 (1997)
Hirai, H.、Okawa, S.、Hangaishi, A.、Takahashi, T.、Hurokawa, M.、Mitani, K.、Ueda, R.、Yazaki, Y.:“白血病发生分子机制的最新进展:
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Tanaka, K,Tanaka, T,Kurokawa, M,Imai, Y,Ogawa, S,Mitani, K,Yazaki, Y,and Hirai, H.: "The AML1/ETO(MTG8)and AML1/Evi-1 leukemia-associated chimeric oncoproteins accumulate PEBP2beta(CBFbeta)in the nucleus more efficiently than wild-type AML1." Blood. (in p
田中 K、田中 T、黑川 M、今井 Y、小川 S、三谷 K、矢崎 Y 和平井 H.:“AML1/ETO(MTG8) 和 AML1/Evi-1 白血病 -
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Mitani, K.: "No concomitant occurrence of the N-ras and p53 gene mutations in myelody-splastic syndron" Leukemia. 11. 863-865 (1997)
Mitani, K.:“骨髓增生异常综合征中 N-ras 和 p53 基因突变没有同时发生”白血病。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 51 条
Analysis of mechanisms in hematopoietic regulation by transcription factors
-
批准号:20390275
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$10.82万
-
财政年份:2008
-
负责人:MITANI Kinuko
-
依托单位:
Molecular mechanism and molecular targeting therapy in transIocation-related leukemia.
-
批准号:17016068
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$28.54万
-
财政年份:2005
-
负责人:MITANI Kinuko
-
依托单位:
Analysis of mechanisms in hematopoietic regulation and leukemia development
-
批准号:17390283
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.7万
-
财政年份:2005
-
负责人:MITANI Kinuko
-
依托单位:
Mechanisms in hematopoiesis and leukemogenesis by the transcription factor TEL
-
批准号:14370308
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.81万
-
财政年份:2002
-
负责人:MITANI Kinuko
-
依托单位:
Development of new immune cell therapies with human leukemia model mouse.
-
批准号:12557078
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$7.49万
-
财政年份:2000
-
负责人:MITANI Kinuko
-
依托单位:
海外基金